The major emphasis of this proposal is to establish more detailed information on the basic biology of glycophorin as a membrane receptor. Glycophorin is the major sialoglycoprotein (SGP) on the surface of mature red blood cells (RBC) and has long been suspected to act as a receptor for malaria parasites. It is our long range goal that this proposed study will be applied toward the development of a model murine system, not only for the study and eradication of malaria and/or sickle cell disease, but also for the development of a more precise biological definition of glycophorin. The overall objective of this proposal is to determine differential expression and incorporation of each murine sialoglycoprotein and to study their structure and function in the RBC membrane during stages of development. In accomplishing these objectives, the following are herein proposed: 1) To screen for differential gene expression and/or developmentally determined incorporation of each SGP type into both fetal and adult maturing RBC using Western blot analysis and specific staining procedures; 2) To ascertain specific concentration or topographic variances of each type of SGP on the surface of fetal versus adult RBC using labelled antibodies and electron microscopy; 3) To construct a recombinant murine cell system from a cell line which does not ordinarily produce glycophorin, but which will now specifically express glycophorin C on its membrane surface with the aid of polymerase chain reaction and transfection. This recombinant cell system will be used for further studies; 4) To determine the ability of murine glycophorin A and C to act as a receptor for a particular serum protein using affinity chromatography and Western blot analysis. Clearly the significance of this study would be found in its contribution towards a more thorough understanding of how surface membrane components play a crucial role in complex function of the cell.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL038737-10
Application #
6109893
Study Section
Project Start
1997-04-01
Project End
2001-03-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
10
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Meharry Medical College
Department
Type
DUNS #
City
Nashville
State
TN
Country
United States
Zip Code
37208
Burch-Sims, G Pamela; Matlock, Valeria R (2005) Hearing loss and auditory function in sickle cell disease. J Commun Disord 38:321-9
Aguinaga, M D; Kutlar, F; Turner, E A et al. (2000) Hb Inkster [alpha85(F6)Asp-->Val] found in a caucasian male with polycythemia. Hemoglobin 24:333-9
Shokrani, M; Terrell, F; Turner, E A et al. (2000) Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin. Ann Clin Lab Sci 30:191-4
Popp, R A; Shinpock, S G; Qopp, D M et al. (1998) Erythropoietin level and effect of rHuEPO in beta-thalassemic mice. Ann N Y Acad Sci 850:455-8
Iyamu, E W; Roa, P D; Kopsombut, P et al. (1998) New isocratic high-performance liquid chromatographic procedure to assay the anti-sickling compound hydroxyurea in plasma with ultraviolet detection. J Chromatogr B Biomed Sci Appl 709:119-26
Roa, D; Kopsombut, P; Aguinaga, M P et al. (1997) Hydroxyurea-induced denaturation of normal and sickle cell hemoglobins in vitro. J Clin Lab Anal 11:208-13
Roa, D; Turner, E A; Aguinaga, M D (1995) Reference ranges for hemoglobin variants by HPLC in African Americans. Ann Clin Lab Sci 25:228-35
Robbins, V; Aguinaga, M P; Valenzuela, M S (1995) Efficient isolation of whole genomic DNA from cell cultures and blood samples. Biotechniques 18:414-6, 418
Roa, P D; Turner, E A; Aguinaga, M del P (1993) Hemoglobin variant detection from dried blood specimens by high performance liquid chromatography. Ann Clin Lab Sci 23:433-8
Chakrabarti, A; Sitaric, S; Ohi, S (1992) A procedure for large-scale plasmid isolation without using ultracentrifugation. Biotechnol Appl Biochem 16:211-5

Showing the most recent 10 out of 17 publications